Feb 25 (Reuters) - Drugmaker Merck (MRK.N), opens new tab said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for government price setting, which would become ...
Lawsuits surrounding Merck's HPV vaccine Gardasil have been piling up for years now, but they've garnered increased public attention lately after HHS Secretary Robert F. Kennedy Jr.'s links to the ...
Merck (NYSE:MRK) and a plaintiff who is suing the drugmaker over allegations that the Gardasil HPV vaccine she received as a teen caused her heart issues and nerve pain have agreed to adjourn the ...
Gilead Sciences has defied analysts’ expectations by passing on its chance to license Arcus Biosciences’ potential rival to Merck & Co.’s kidney cancer drug Welireg. Gilead had the right to ...
Trial adjourned, new jury due to reconvene in September Kennedy helped organize litigation against Merck before HHS role Merck denies claims, cites scientific evidence supporting Gardasil safety ...
Merck & Co. Inc. misled investors about traction for its HPV vaccine in China, sending the stock down when it revealed oversaturated inventory and that it would fall short of its expected $11 billion ...
Germany's Merck KGaA said it is in advanced talks for a potential acquisition of SpringWorks Therapeutics, a U.S. biopharmaceutical company that specializes in rare diseases and cancer.
Merck KGaA said it’s in advanced talks to purchase SpringWorks Therapeutics Inc., sending shares of the US cancer and rare diseases drugmaker soaring. One of SpringWorks’ drugs, Ogsiveo, is ...
Across the recent three months, 12 analysts have shared their insights on Merck & Co (NYSE:MRK), expressing a variety of opinions spanning from bullish to bearish. In the table below, you'll find ...
The Merck Manuals Online Medical Library Clinical Pharmacology Section: provides a general review of pharmacokinetic parameters: absorption, bioavailability, distribution, excretion and metabolism ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results